SOR-007 by Nanology for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
SOR-007 is under clinical development by Nanology and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas.
SOR-007 is under clinical development by Nanology and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas.
What's Your Reaction?
